|Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 …|
AD Roth, S Tejpar, M Delorenzi, P Yan, R Fiocca, D Klingbiel, D Dietrich, ...
Journal of clinical oncology 28 (3), 466-474, 2010
|Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features|
E Missiaglia, B Jacobs, G D'ario, AF Di Narzo, C Soneson, E Budinska, ...
Annals of oncology 25 (10), 1995-2001, 2014
|Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer|
AD Roth, M Delorenzi, S Tejpar, P Yan, D Klingbiel, R Fiocca, G d’Ario, ...
Journal of the National Cancer Institute 104 (21), 1635-1646, 2012
|Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial|
D Klingbiel, Z Saridaki, AD Roth, FT Bosman, M Delorenzi, S Tejpar
Annals of oncology 26 (1), 126-132, 2015
|Microsatellite instability (MSI) in stage II and III colon cancer treated with 5FU-LV or 5FU-LV and irinotecan (PETACC 3-EORTC 40993-SAKK 60/00 trial)|
S Tejpar, F Bosman, M Delorenzi, R Fiocca, P Yan, D Klingbiel, D Dietrich, ...
Journal of Clinical Oncology 27 (15_suppl), 4001-4001, 2009
|Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)|
AJ Templeton, V Dutoit, R Cathomas, C Rothermundt, D Bärtschi, ...
European urology 64 (1), 150-158, 2013
|Expression profiling of human idiopathic dilated cardiomyopathy|
R Grzeskowiak, H Witt, M Drungowski, R Thermann, S Hennig, A Perrot, ...
Cardiovascular research 59 (2), 400-411, 2003
|Final results of a prospective evaluation of the predictive value of interim positron emission tomography in patients with diffuse large B-cell lymphoma treated with R-CHOP-14 …|
C Mamot, D Klingbiel, F Hitz, C Renner, T Pabst, C Driessen, U Mey, ...
Journal of clinical oncology 33 (23), 2523-2529, 2015
|A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma|
C Renner, PL Zinzani, R Gressin, D Klingbiel, PY Dietrich, F Hitz, ...
Haematologica 97 (7), 1085-1091, 2012
|Hyperthermia and radiation therapy in locoregional recurrent breast cancers: a systematic review and meta-analysis|
NR Datta, E Puric, D Klingbiel, S Gomez, S Bodis
International Journal of Radiation Oncology* Biology* Physics 94 (5), 1073-1087, 2016
|Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib …|
GA Pesce, D Klingbiel, K Ribi, A Zouhair, R Von Moos, M Schlaeppi, ...
European journal of cancer 48 (3), 377-384, 2012
|A cost-effectiveness analysis of nivolumab versus docetaxel for advanced nonsquamous NSCLC including PD-L1 testing|
K Matter-Walstra, M Schwenkglenks, S Aebi, K Dedes, J Diebold, ...
Journal of Thoracic Oncology 11 (11), 1846-1855, 2016
|Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. 2010|
AD Roth, S Tejpar, M Delorenzi, P Yan, R Fiocca, D Klingbiel
J Clin Oncol. Jan 20 (28), 3, 0
|Prognostic impact of deficient mismatch repair (dMMR) in 7,803 stage II/III colon cancer (CC) patients (pts): A pooled individual pt data analysis of 17 adjuvant trials in the …|
DJ Sargent, Q Shi, G Yothers, S Tejpar, MM Bertagnolli, SN Thibodeau, ...
Journal of Clinical Oncology 32 (15_suppl), 3507-3507, 2014
|The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a …|
F Strasser, D Blum, R Von Moos, R Cathomas, K Ribi, S Aebi, D Betticher, ...
Annals of Oncology 27 (2), 324-332, 2016
|Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses|
NR Datta, S Rogers, D Klingbiel, S Gómez, E Puric, S Bodis
International Journal of Hyperthermia 32 (7), 809-821, 2016
|Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: a systematic review and meta-analysis|
NR Datta, E Stutz, M Liu, S Rogers, D Klingbiel, A Siebenhüner, S Singh, ...
Gynecologic Oncology 145 (2), 374-385, 2017
|Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05)|
M Joerger, F Baty, M Früh, C Droege, RA Stahel, DC Betticher, ...
Lung Cancer 85 (2), 306-313, 2014
|Standardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 study|
Z Varga, E Cassoly, Q Li, C Oehlschlegel, C Tapia, HA Lehr, D Klingbiel, ...
PLoS One 10 (4), e0123435, 2015
|Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07)|
R Cathomas, C Rothermundt, D Klingbiel, L Bubendorf, R Jaggi, ...
Clinical cancer research 18 (21), 6049-6057, 2012